Abstract: The invention concerns a mold for forming an element for covering a lining of a seat member for a motor vehicle, comprising: a matrix (62) provided with ribs (624) for defining style extension lines (36); and a punch (64) provided with ribs (642), to either side of a line of the ribs (624) of the matrix (62).
Type:
Grant
Filed:
August 1, 2014
Date of Patent:
October 29, 2019
Assignee:
Faurecia Sieges D'Automobile
Inventors:
Olivier Rigal, Fabrice Etienne, Benoit Gazaniol, Carlos Kochinski
Abstract: Compounds of formula (I): wherein R1, R2, R3, R4, R5, R6 and Y are as defined in the description. Medicaments.
Type:
Grant
Filed:
December 19, 2016
Date of Patent:
October 29, 2019
Assignees:
LES LABORATOIRES SERVIER, VERNALIS (R&D) LTD
Inventors:
Attila Paczal, Zoltán Szlávik, András Kotschy, Maïa Chanrion, Ana Leticia Maragno, Olivier Geneste, Didier Demarles, Balázs Bálint, Szabolcs Sipos
Abstract: The invention relates to a member 24 for a system for connecting a wiper blade to a windscreen wiper arm, comprising means 80 of articulation about an axis Y of pivoting and configured in order to interact with complementary means of a second member of the connection system, characterized in that the articulation means comprise at least one hole 80 comprising at least two portions 80a, 80b of a cylinder having radii R1, R2, which are constant and different, each cylinder forming a rotation bearing.
Type:
Grant
Filed:
June 27, 2016
Date of Patent:
October 29, 2019
Assignee:
Valeo Systèmes d'Essuyage
Inventors:
Philippe Espinasse, Marie-Therese Hanino
Abstract: In the present invention an alkali vapor cell is proposed comprising a sealed chamber enclosing an alkali atomic gas therein and having at least one optically transparent window. The chamber and the transparent window define an optical beam path through which a light beam can pass and which interacts with the alkali atomic gas in the chamber. The alkali vapor cell comprises at least one localized condensation area of alkali atoms at a predetermined location in the sealed chamber and the predetermined location is located inside or outside the optical beam path. The localized condensation area has higher alkali metal wettability than any other surface portion of the alkali vapor cell outside said localized condensation area.
Type:
Grant
Filed:
May 10, 2017
Date of Patent:
October 29, 2019
Assignee:
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA—RECHERCHE ET DÉVELOPPEMENT
Inventors:
Jean Gobet, Thomas Overstolz, Fabien Droz-dit-Busset
Abstract: The present invention relates to a time-multiplexed stereoscopic 3d projection system wherein the image-beam from a digital cinema projector is separated by a polarization beam-splitting element into one primary image-beam possessing a first state of polarization and at least one secondary image-beam possessing a second state of polarization. Polarization modulators are provided in order to modulate the polarization state for each of said primary and secondary image-beams thereof and arranged so that all left-eye images possess a first modulated state of polarization and all right-eye images possess a second modulated state of polarization.
Abstract: A method of preparation of stereospecific synthesis of diastereomerically pure phosphorodiamidate morpholino oligomers (PMOs) of one of the following general formulas is provided:
Type:
Grant
Filed:
August 5, 2016
Date of Patent:
October 29, 2019
Assignee:
Eisai R&D Management Co., Ltd
Inventors:
Atsushi Endo, Robert T. Yu, Francis Fang, Hyeong Wook Choi, Mingde Shan
Abstract: The present invention concerns a device for cleaning a sensor of a motor vehicle. The device in accordance with the invention includes means for simultaneous or sequential distribution via a distribution orifice (11) in a distribution nozzle (1) of a first fluid and/or a second fluid separately routed via a first admission channel (2) and/or via a second admission channel (3), respectively, to a common distribution chamber (10) in said distribution nozzle (1). It also includes means for moving said distribution nozzle (1) between a rest position and a deployed position, and these said means for moving the distribution nozzle (1) include means shared with the means for feeding the first admission channel (2) with the first fluid.
Abstract: The present invention relates to extravascular supports. In particular, to extravascular supports which are used in vein grafting. More in particular, it relates to extravascular supports which are biodegradable.
Abstract: An intubation device for placing a tracheal tube into a patient's trachea. The intubation device comprises a flexible light-wand having light emitting means placed in a distal end portion thereof. A distal portion of the flexible light-wand is adapted for placement inside the tracheal tube with the distal end portion thereof being in proximity to a distal end of the tracheal tube. The intubation device further comprises a coupling conduit. The coupling conduit has a tracheal tube port for being connected to the tracheal tube placed at a distal end thereof, a ventilating port for being connected to a ventilatory source, a monitoring port for being connected to a respiratory gas monitor, and a sealed aperture placed at a proximal end thereof. The sealed aperture accommodates the flexible light wand therethrough in a sealed fashion such that ventilating and monitoring of the patient is enabled while the flexible light wand is placed in the tracheal tube.
Type:
Grant
Filed:
June 20, 2014
Date of Patent:
October 29, 2019
Assignee:
SCOTIA M.D. ENGINEERING INC.
Inventors:
Orlando Ricardo Hung, Andrew Davidson Milne, Matthew Ivan d'Entremont
Abstract: A perimeter warning system is provided having a plurality of substantive stand bases and stanchions, which when combined together with a flag line provide a means to demark the perimeter of a surface across which there is danger. The stand bases include a surface onto which an insertion sleeve is placed, for holding the stanchion stably, and an opening symmetrically equidistant from the center of the surface of the stand base from the sleeve. In this way, stand bases can be stacked together with the sleeve of one placed in the opening in the surface of the other for stability. The system includes storage and transportation elements; wherein the surface of the base stand defines an opening through which the pillar of a storage unit can be threaded to stack the plurality of base stands together onto the storage element. Stanchions are provided with storage boxes configured to stack together neatly and stably.
Abstract: Compounds of formula (I): wherein R1, R2, R5, R6, R7, R12, X, Y, A, E and n are as defined in the description. Medicinal products containing the same which are useful in treating a condition requiring a pro-apoptotic agent.
Type:
Grant
Filed:
June 22, 2016
Date of Patent:
October 29, 2019
Assignees:
LES LABORATOIRES SERVIER, VERNALIS (R&D) LTD
Inventors:
Zoltán Szlávik, Zoltán Szabó, Márton Csékei, Attila Paczal, András Kotschy, Alain Bruno, Olivier Geneste, I-Jen Chen, James Edward Paul Davidson, James Brooke Murray, Levente Ondi, Gábor Radics, Szabolcs Sipos, Ágnes Proszenyák, Françoise Perron-Sierra, Balázs Bálint
Abstract: In some embodiments, data is received defining a plurality of shot groups that will be delivered by a charged particle beam writer during an overall time period, where a first shot group will be delivered onto a first designated area at a first time period. A temperature of the first designated area at a different time period is determined. In some embodiments, the different time period is when secondary effects of exposure from a second shot group are received at the first designated area. In some embodiments, transient temperatures of a target designated area are determined at time periods when exposure from a shot group is received. An effective temperature of the target area is determined, using the transient temperatures and applying a compensation factor based on an amount of exposure received during that time period. A shot in the target shot group is modified based on the effective temperature.
Type:
Grant
Filed:
October 20, 2016
Date of Patent:
October 29, 2019
Assignee:
D2S, Inc.
Inventors:
Akira Fujimura, Harold Robert Zable, Ryan Pearman, William Guthrie
Abstract: Nucleoside analogues that can be used as anticancer or antiviral agents are presented. These compounds are nucleoside and/or nucleotide prodrugs. In particular, the subject matter relates to nucleoside analogues comprising a tetrahydrofuranyl, or tetrahydrothienyl moiety which: have a quaternary stereogenic all-carbon center at the 3? position and bear a phosphoryl group at either one of, or both of positions C5? and/or C3?; have a quaternary stereogenic all-carbon center at one of the 3? position, 2? position, or no quaternary stereogenic center at all, and bear a ?-blocked lipoate derivative attached through an amide bond to the primary amine of the nucleobase; or have a quaternary stereogenic all-carbon center at the 2? position and bear a phosphorylated prodrug at the C5?-position and a ?-blocked lipoate derivative attached through an amide bond to the primary amine of the nucleobase.
Type:
Application
Filed:
September 18, 2017
Publication date:
October 24, 2019
Applicants:
LCB PHARMA INC., UNIVERSITÉ D'OTTAWA
Inventors:
Yvan GUINDON, Philippe MOCHIRIAN, Mona NEMER, Michel PRÉVOST
Abstract: The present invention relates to axial flow chromatography columns, methods for separating one or more analytes in a liquid by the use of such columns, and systems employing such columns. The column comprises a first port and a second port the first port and said second port being at essentially the same level or elevation above the level of the bed space on the chromatography column.
Abstract: A method and an apparatus for forwarding a heterogeneous protocol message, and a network switching device are provided, the method includes: receiving a network message; parsing the network message to obtain a destination address of the network message; looking up in a preset forwarding table a port corresponding to the destination address and a first protocol corresponding to the port; judging whether the first protocol matches a second protocol of the network message; performing, if not, protocol conversion on the network message in accordance with a preset conversion rule, so that the protocol type of the network message matches the port; forwarding the protocol-converted network message through the port. In the present disclosure, protocol conversion can be performed on messages from different protocol networks, so that the network switching device implements communication between different networks, and has a flexible protocol processing mode and powerful scalability.
Type:
Application
Filed:
April 5, 2019
Publication date:
October 24, 2019
Applicants:
Tianjin Chip Sea Innovation Technology Co. Ltd., China National Digital Switching System Engineering & Tech R&D Center
Abstract: The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form.
Type:
Application
Filed:
June 27, 2019
Publication date:
October 24, 2019
Applicant:
THERAVANCE BIOPHARMA R&D IP, LLC
Inventors:
Shaoling Li, Manshiu Leung, Hao Zhang, Venkat R. Thalladi, Yun Mo